Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7613223rdf:typepubmed:Citationlld:pubmed
pubmed-article:7613223lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C0018183lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C1321301lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C1819437lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C0721534lld:lifeskim
pubmed-article:7613223lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:7613223pubmed:issue1-3lld:pubmed
pubmed-article:7613223pubmed:dateCreated1995-8-24lld:pubmed
pubmed-article:7613223pubmed:abstractTextProlonged culture of human peripheral blood monocytes hPBMs requires the addition of both granulocyte/macrophage-colony-stimulating factor (GM-CSF) and interferon (IFN)-gamma. Cultured hPMBs challenged with lipopolysaccharide produced large amounts of several cytokines but very little interleukin (IL)-10. However, when GM-CSF and IFN-gamma were omitted from the cultures, IL-10 production was readily demonstrated. Addition of IL-10 to the cultures potently inhibited the production of several cytokines and, in the presence of GM-CSF and IFN-gamma, there was no loss in cell number. In contrast, when IL-10 was added to cultures in the absence of GM-CSF and IFN-gamma, there was an accelerated loss of viable cells. A monoclonal antibody to IL-10, which had no effect on cell survival in the presence of GM-CSF and IFN-gamma, partly prevented the loss of cells which occurred in the absence of IL-10 and these additives. Preliminary studies suggest that inclusion of anti-IL-10 can partly prevent the apoptosis which occurs when GM-CSF and IFN-gamma are omitted from the cultures. These observations suggest that there is a cause and effect relationship between the failure of hPBMs to produce IL-10 when they are cultured in the presence of GM-CSF and IFN-gamma and protection from apoptosis by these additives.lld:pubmed
pubmed-article:7613223pubmed:languageenglld:pubmed
pubmed-article:7613223pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:citationSubsetIMlld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7613223pubmed:statusMEDLINElld:pubmed
pubmed-article:7613223pubmed:issn1018-2438lld:pubmed
pubmed-article:7613223pubmed:authorpubmed-author:BachM KMKlld:pubmed
pubmed-article:7613223pubmed:authorpubmed-author:BrashlerJ RJRlld:pubmed
pubmed-article:7613223pubmed:issnTypePrintlld:pubmed
pubmed-article:7613223pubmed:volume107lld:pubmed
pubmed-article:7613223pubmed:ownerNLMlld:pubmed
pubmed-article:7613223pubmed:authorsCompleteYlld:pubmed
pubmed-article:7613223pubmed:pagination90-2lld:pubmed
pubmed-article:7613223pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:meshHeadingpubmed-meshheading:7613223-...lld:pubmed
pubmed-article:7613223pubmed:articleTitleEvidence that granulocyte/macrophage-colony-stimulating factor and interferon-gamma maintain the viability of human peripheral blood monocytes in part by their suppression of IL-10 production.lld:pubmed
pubmed-article:7613223pubmed:affiliationUpjohn Laboratories, Kalamazoo, MI 49001, USA.lld:pubmed
pubmed-article:7613223pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7613223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7613223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7613223lld:pubmed